Trump administration moves forward with certain drug reclassifications
CBS News
—
President Trump signed an executive order on Saturday that paves the way for more research into psychedelics as treatment for certain mental illnesses.
The signing follows Mr. Trump's move in December 2025 to reclassify marijuana as a less dangerous drug.
Josh Kesselman, the founder of RAW rolling papers and publisher of High Times Magazine, joins with more.
Trump's psychedelics executive order
- Compass Pathways CEO on Trump's Order to Expand Psychedelics Research Bloomberg —
- FDA's Makary on Trump EO to Ease Access to Psychedelics Bloomberg —
- Trump’s order on psychedelics could have far-reaching science consequences Scientific American —
- How Trump's psychedelics executive order could unlock stalled cannabis reform CNBC —
- Trump administration moves forward with certain drug reclassifications CBS News —